...
机译:Brentuximab Vedotin或医生在CD30-阳性皮肤T细胞淋巴瘤(Alcanza)中的选择:国际,开放标签,随机,第3阶段,多期式试验
Univ Melbourne Peter MacCallum Canc Ctr Div Canc Med Melbourne Vic Australia;
Stanford Univ Sch Med Dept Dermatol Stanford CA 94305 USA;
Mem Sloan Kettering Canc Ctr Dept Med 1275 York Ave New York NY 10021 USA;
Univ Hosp Zurich Dept Dermatol Zurich Switzerland;
Univ Hosp Birmingham Dept Dermatol Birmingham W Midlands England;
Univ Turin Dept Med Sci Dermatol Clin Turin Italy;
Univ Bologna Inst Haematol Bologna Italy;
Univ Hosp Leuven Dept Gen Med Oncol Leuven Belgium;
Univ Sao Paulo Sch Med Dept Dermatol Sao Paulo Brazil;
Univ Complutense Univ Hosp Octubre 12 Inst Med Sch I 12 Madrid Spain;
Univ Pittsburgh Dept Dermatol Pittsburgh PA 15260 USA;
Univ Pittsburgh Dept Dermatol Pittsburgh PA 15260 USA;
Univ Sydney Concord Repatriat Gen Hosp Dept Haematol Concord NSW Australia;
ICON Canc Care South Brisbane Qld Australia;
Claude Bernard Lyon 1 Univ Hosp Civils Lyon Dept Dermatol Lyon France;
Univ Hosp Schleswig Holstein Dept Dermatol Kiel Germany;
Maria Sklodowska Curie Inst Warsaw Poland;
Dana Farber Canc Inst Boston MA 02115 USA;
Nantes Univ Fac Med Nantes France;
Johannes Wesling Med Ctr Univ Clin Dermatol Minden Germany;
Hackensack Univ Med Ctr John Theurer Canc Ctr Hackensack NJ USA;
Rush Univ Dept Med Div Hematol Oncol Cell Therapy Chicago IL 60612 USA;
Seattle Genet Inc Bothell WA USA;
Seattle Genet Inc Bothell WA USA;
Takeda Pharmaceut Co Ltd Millennium Pharmaceut Inc Cambridge MA USA;
Takeda Pharmaceut Co Ltd Millennium Pharmaceut Inc Cambridge MA USA;
Takeda Pharmaceut Co Ltd Millennium Pharmaceut Inc Cambridge MA USA;
Takeda Pharmaceut Co Ltd Millennium Pharmaceut Inc Cambridge MA USA;
Takeda Pharmaceut Co Ltd Millennium Pharmaceut Inc Cambridge MA USA;
Takeda Pharmaceut Co Ltd Millennium Pharmaceut Inc Cambridge MA USA;
Takeda Pharmaceut Co Ltd Millennium Pharmaceut Inc Cambridge MA USA;
Guys &
St Thomas NHS Fdn Trust St Johns Inst Dermatol London England;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
机译:Brentuximab Vedotin或医生在CD30-阳性皮肤T细胞淋巴瘤(Alcanza)中的选择:国际,开放标签,随机,第3阶段,多期式试验
机译:Brentuximab Vedotin具有化学疗法,用于CD30阳性外周T细胞淋巴瘤(Echelon-2):全球,双盲,随机,第3阶段试验(Vol 393,PG 229,2019)
机译:Brentuximab Vedotin具有化学疗法,用于CD30阳性外周T细胞淋巴瘤(Echelon-2):全球,双盲,随机,第3期试验
机译:Brentuximab Vedotin II期临床试验结果用于CD30 +皮肤T细胞淋巴瘤和淋巴瘤样丘疹
机译:Brentuximab Vedotin治疗复发CD30阳性皮肤淋巴瘤 - 国际,开放标签,随机,第3阶段,Multicentre试验 - Alcanza的结果